Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital.

Author: AlvesCarlos, Batel-MarquesFrancisco, MendesDiogo, PenedonesAna, RigueiroGraça, SilvaRui S, SousaGabriela

Paper Details 
Original Abstract of the Article :
PURPOSE: The aim of this study was to test the feasibility and the usefulness of an intensive safety monitoring program to identify adverse drug reactions for medicines under additional monitoring that are used to treat cancer patients within a Portuguese oncology hospital. METHODS: This pilot inte...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/1078155219849277

データ提供:米国国立医学図書館(NLM)

Intensive Safety Monitoring: A Vigilant Watch Over Cancer Medications

The field of [pharmacovigilance] focuses on ensuring the safety of medications and identifying potential adverse drug reactions. This pilot study explores the feasibility and usefulness of an intensive safety monitoring program for antineoplastic medications in a Portuguese oncology hospital. The authors evaluated the program's effectiveness in identifying adverse drug reactions (ADRs) in patients receiving medications under additional monitoring. Their findings demonstrate the program's effectiveness in identifying serious and unexpected ADRs, highlighting its value for improving patient safety.

Intensive Monitoring: A Key to Safe Cancer Treatment

This research underscores the importance of comprehensive safety monitoring programs in oncology settings. The authors observed that the intensive monitoring program effectively detected serious and unexpected ADRs, demonstrating its crucial role in identifying potential risks associated with antineoplastic medications. This finding highlights the need for robust pharmacovigilance systems to ensure patient safety during cancer treatment.

Protecting Patients from Unexpected Side Effects

This research highlights the importance of vigilant monitoring for potential side effects associated with medications, especially in patients receiving cancer treatment. It's a reminder to be proactive in reporting any unusual symptoms to healthcare professionals to ensure prompt management and prevent potentially serious complications. This research encourages a culture of safety and vigilance in oncology care, prioritizing the well-being of patients undergoing treatment.

Dr. Camel's Conclusion

This research is a reminder that even in the exciting advancements in cancer treatment, safety must remain a top priority. The implementation of intensive safety monitoring programs is like setting up a vigilant lookout post in the desert of cancer care, ensuring that patients are protected from potential hazards. This vigilance is essential for navigating the complexities of cancer treatment and ensuring the well-being of those who are battling this challenging disease.

Date :
  1. Date Completed 2020-02-17
  2. Date Revised 2020-02-17
Further Info :

Pubmed ID

31117914

DOI: Digital Object Identifier

10.1177/1078155219849277

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.